Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease that
manifests as vascular malformations in the brain, lung, liver, gastrointestinal tract, nasal …

Hemorrhagic hereditary telangiectasia (HHT) is a rare autosomal dominant disorder that
causes multisystem vascular malformations including mucocutaneous telangiectasias and …

Purpose Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-
organ vascular disorder that commonly affects the gastrointestinal tract and the liver …

Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by
telangiectases and arteriovenous malformations (AVMs) in particular locations described in …

Background HHT is an autosomal dominant disease with an estimated prevalence of at least
1/5000 which can frequently be complicated by the presence of clinically significant …

Hereditary haemorrhagic telangiectasia (HHT) is a complex, multisystemic vascular
dysplasia affecting approximately 85,000 European Citizens. In 2016, eight founding centres …

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder
characterized by vascular dysplasia, including typically systemic telangiectases and …

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder
characterized by epistaxis, telangiectases, and multi-organ vascular dysplasia. Head and …

Hereditary hemorrhagic telangiectasia (HHT), also known by the eponym Osler–Weber–
Rendu syndrome, is a group of related disorders inherited in an autosomal dominant fashion …

Hereditary haemorrhagic telangiectasia, inherited as an autosomal dominant trait, affects
approximately 1 in 5000 people. The abnormal vascular structures in HHT result from …